scorecardresearch
Add as a preferred source on Google
Friday, December 19, 2025
TopicMedicines

Topic: Medicines

No animal testing, human volunteers—how new-age ‘in silico’ trials will make drugs cheaper

Drug and medical device development through clinical trials can cost anywhere between $50 million to $1 billion. Computer-based testing can change that.

Western companies should supply essential medicines to Ukraine, not pull out entirely

Putin may not be swayed by the suffering of people. Any interruption of supply of medicines can create human misery without any gain.

Mumbai-based generics start-up Zeno Health to scale operations across India

Zeno has changed the way medicines are sold and consumed by aiding consumers to make informed decisions on their monthly medicine expenditure.

How desi Dolo 650 outsold MNC GSK’s Crocin, became India’s ‘favourite snack’ in Covid waves

Dolo 650 is now India’s favoured paracetamol brand, with sales of Rs 567 crore since March 2020. It’s even trending on social media and is the subject of memes.

Google parent Alphabet will use AI to discover drugs

Alphabet lab DeepMind’s algorithms have made huge advances in predicting shapes of proteins, a technology that could speed up development of new drugs & upend pharma industry.

Self-medication for Covid has turned disastrous. Families must not assume doctors’ role

The collective confusion over Covid-19 treatment has led to a compulsive, panic-driven behaviour among Indians. We must return to the idea of 'under doctor’s supervision'.

Drugmakers want Modi govt to defer revision of essential medicines list, cite Covid crisis

Drugmakers have also requested the government to consider ‘essentiality’ of the drug, and not its ‘turnover’, as the criterion for inclusion under NLEM.

Prices of some medicines could go up as cost of Chinese bulk drugs import surges

Drug makers have reached out to Modi govt with a proposal to bring a law under which price hikes could be made possible due to unforeseen factors.

‘Covid drug’ favipiravir to be available at Rs 103/tablet by month-end

Favipiravir, an antiviral medication developed in Japan, is currently the subject of 18 trials around the world as a potential treatment for Covid-19.

Not just for flu but even BP and gynaecology — how telemedicine is filling a Covid vacuum

Virtual platforms say they have recorded a significant rise in number of patients during the lockdown. And the increase isn’t restricted to flu-related e-consultations.

On Camera

Young India’s cultural assertion isn’t conservatism—it’s course correction

Indian Gen Z is assertive because boomers and millennials were docile and apologetic. We are Indian, and we are proud.

China is taking India to WTO over subsidies, again. Here’s what it’s arguing before trade body

Dispute will now move to consultative process, which allows the two sides to come to an amicable agreement within 60 days.

Israel has ‘realised who its real friend is’, eyes defence expansion in India amid arms curbs by others

It is argued that India-Israel ties are moving from buyer–seller dynamic to one focused on joint development & manufacturing partnership, a shift 'more durable' than traditional arms sales.

India’s top airline just handed sarkar the keys. That’s IndiGo’s real ‘crime’

Don’t blame misfortune. This is colossal incompetence and insensitivity. So bad, heads would have rolled even in the old PSU-era Indian Airlines and Air India.